Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …

Y Hanai, Y Takahashi, T Niwa, T Mayumi… - Journal of …, 2022 - academic.oup.com
Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …

[HTML][HTML] Developmental pharmacokinetics of antibiotics used in neonatal ICU: focus on preterm infants

OI Butranova, EA Ushkalova, SK Zyryanov… - Biomedicines, 2023 - mdpi.com
Neonatal Infections are among the most common reasons for admission to the intensive
care unit. Neonatal sepsis (NS) significantly contributes to mortality rates. Empiric antibiotic …

[HTML][HTML] Use of antibiotics in preterm newborns

R Simeoli, S Cairoli, N Decembrino, F Campi… - Antibiotics, 2022 - mdpi.com
Due to complex maturational and physiological changes that characterize neonates and
affect their response to pharmacological treatments, neonatal pharmacology is different from …

[HTML][HTML] Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: recent advancements and prospects in …

K Oda, H Saito, H Jono - Pharmacology & Therapeutics, 2023 - Elsevier
As one of the efficient techniques for TDM, the population pharmacokinetic (popPK) model
approach for dose individualization has been developed due to the rapidly growing …

Population pharmacokinetics of unbound and total teicoplanin in critically ill pediatric patients

LBS Aulin, P De Paepe, E Dhont, A de Jaeger… - Clinical …, 2021 - Springer
Abstract Background and Objectives Teicoplanin is a highly protein-bound antibiotic,
increasingly used to treat serious Gram-positive infections in critically ill children …

[HTML][HTML] Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis

CY Chen, M Xie, J Gong, N Yu, R Wei, LL Lei… - Frontiers in …, 2023 - frontiersin.org
Objectives: Teicoplanin has been extensively used in the treatment for infections caused by
gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) …

Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus in neutropenic patients …

X Wei, M Zhao, X Xiao - Journal of Chemotherapy, 2021 - Taylor & Francis
The objective of this study was to evaluate the efficacy of various dosing regimens of
vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant …

Optimal teicoplanin dosing regimen in neonates and children developed by leveraging real-world clinical information

T Yamada, C Emoto, T Fukuda… - Therapeutic drug …, 2022 - journals.lww.com
Background: Teicoplanin is a glycopeptide antibiotic used for the treatment of methicillin-
resistant Staphylococcus aureus infections. To ensure successful target attainment …

《 2022 JSC/JSTDM 临床实践指南: 替考拉宁治疗药物监测》 解读

王润 - 广州医药, 2023 - gzyyzz.cn
目的为临床合理使用替考拉宁以及更好地管理接受替考拉宁治疗的患者.
方法从药学角度对2022 年日本《 2022 JSC/JSTDM 临床实践指南: 替考拉宁治疗药物监测》 …